267
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Biosimilar versus InnovAtor MoLecule of RAnibizumab in Neovascular Age-Related MaCular DEgeneration (The BALANCE Trial): Real-World Evidence

ORCID Icon, , , , , , & ORCID Icon show all
Pages 1067-1076 | Received 17 Feb 2023, Accepted 28 Mar 2023, Published online: 08 Apr 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.